Overview

• Madhya Pradesh FDA said another bottle from the same Coldrif batch failed, with a Jabalpur sample bringing the tally of failed tests to four that detected diethylene glycol at lethal levels.
• Delhi’s Drugs Control Department banned sale and use of the named batch after a government lab declared it not of standard quality, citing DEG contamination, and officials said no consignment reached the city as they began wider sampling.
• Sresan Pharma owner G. Ranganathan was arrested in Chennai and remanded to 10 days’ police custody in Parasia, with investigators examining the manufacturing process, suppliers, and quality checks.
• CDSCO sources reported serious GMP violations at the Sresan unit and flagged lapses by Tamil Nadu’s regulator, while the state health minister countered that central inspectors had not conducted required checks in recent years.
• States expanded bans and recalls as authorities reported most of roughly 660 Coldrif bottles sold in Chhindwara were recovered, two children remained critical in Nagpur, and opposition leaders sought the MP health minister’s resignation and a CBI probe.